Lisata Therapeutics Inc. (LSTA)
NASDAQ: LSTA
· Real-Time Price · USD
2.48
-0.02 (-0.60%)
At close: Jun 16, 2025, 1:57 PM
Lisata Therapeutics Revenue Breakdown
| Period Ending | Dec 31, 2024 |
|---|---|
| Reportable Segment Revenue | 1M |
| Reportable Segment Revenue Growth | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 3.25M | 3M | 2.79M | 2.92M | 3.31M | 3.01M | 2.58M | 3.71M | 3.67M | 3.37M | 3.95M | 3.48M | 3.34M | 2.7M | 2.84M | 2.82M | 3.01M | 2.54M | 2.32M | 2.47M | 2.56M | 2.31M | 2.07M | 2.36M | 2.55M | 2.29M | 2.06M | 2.15M | 2.9M | 2.67M | 2.94M | 3.43M | 5.95M | 4.23M | 4.94M | 4.71M | 6.46M | 5.03M | 5.15M | 8.74M | 11.09M |
| Selling, General, and Administrative Revenue Growth | +8.20% | +7.34% | -4.38% | -11.83% | +10.03% | +16.56% | -30.41% | +1.31% | +8.72% | -14.59% | +13.39% | +4.16% | +23.82% | -5.07% | +0.89% | -6.38% | +18.55% | +9.39% | -6.18% | -3.28% | +10.50% | +11.94% | -12.30% | -7.67% | +11.63% | +10.96% | -3.96% | -25.86% | +8.55% | -9.34% | -14.27% | -42.29% | +40.67% | -14.32% | +4.89% | -27.13% | +28.29% | -2.20% | -41.08% | -21.21% | n/a |
| Research and Development Revenue | 2.6M | 2.95M | 2.54M | 2.6M | 3.24M | 3.01M | 3.38M | 3.16M | 3.18M | 3.17M | 33.77M | 3.24M | 3.28M | 4.15M | 4.13M | 4.33M | 5.08M | 2.91M | 3.03M | 1.82M | 1.5M | 2.77M | 3M | 2.99M | 2.04M | 1.51M | 2.3M | 2.72M | 2.86M | 5.25M | 3.59M | 4.28M | 3.73M | 2.57M | 2.96M | 4.49M | 5.88M | 3.18M | 6.32M | 7.6M | 6.8M |
| Research and Development Revenue Growth | -11.80% | +16.05% | -2.27% | -19.75% | +7.57% | -10.86% | +6.89% | -0.53% | +0.32% | -90.62% | +942.70% | -1.19% | -21.01% | +0.61% | -4.71% | -14.72% | +74.61% | -4.03% | +66.61% | +21.28% | -45.83% | -7.89% | +0.54% | +46.61% | +35.15% | -34.46% | -15.50% | -4.86% | -45.51% | +46.42% | -16.15% | +14.81% | +44.76% | -13.01% | -34.08% | -23.60% | +84.84% | -49.67% | -16.91% | +11.71% | n/a |